This article describes the study "Exercise serum promotes DNA damage repair and remodels gene expression in colon cancer cells" by Samuel T Orange et al., published in the International Journal of Cancer. However, the article does not link to the original study.

~

The article's headline is highly misleading. The researchers did not find that quick exercise can "halt bowel cancer".

~

They applied blood from people who had just done a short cycling exercise to cancer cells in a dish in the lab. They found that these cancer cells expressed more genes and proteins associated with immune response, DNA repair, and reduced growth.

~

This is promising, because it suggests exercise might slow cancer cell growth. But it was only shown in the lab; the study has not proved that exercise can completely stop or "halt" cancer cell growth in the human body.

~

This article wrongly says the study was done in 30 men. The study was actually done in 17 male and 12 female participants. All were overweight or obese, and 29 out of 30 participants were White British. So the results may not be accurate for people with different weights or ancestries.

~

Finally, the article only quotes one scientist, Dr. Orange, the same person who did the study, so is biased in its interpretation of the results.

This article is an accurate and unbiased description of the findings of a study published in the reliable journal Nature Medicine, called "Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial" by Huang et al.

The study found that improved progression-free survival was seen in patients who received immunotherapy earlier in the day.

The article presents balanced views of other experts, that these findings need to be replicated in other populations before they can be 100% believed. It also highlights other studies which agree that timing does influence immune system activity.

This article was written on 6th February 2026. After its publication, on 19th February 2026, the study by Huang et al. started being investigated by editors of the journal, due to differences in the originally planned study method (written about on https://clinicaltrials.gov/study/NCT05549037 ) vs. the method published in the Nature Medicine paper. Therefore, the findings of this study should be taken with a pinch of salt, until the investigation is resolved.

As a cancer researcher studying non-small cell lung cancer (NSCLC), I thought the technical terminology and definitions used in this article were accurate.